Dyslipidemia - From Prevention to Treatment

00 prefaceDYSLIPIDEMIA - FROM PREVENTION TO TREATMENT......Page 1
01 Obesity Related Lipid Profile and Altered\rInsulin Incretion in Adolescent with\rPolicystic Ovary Syndrome......Page 13
02 Ethnic Difference in Lipid Profiles......Page 27
03 Nutrigenetics and Dyslipidemia......Page 53
04 Impact of Climate Change and\rAir Pollution on Dyslipidemia and\rthe Components of Metabolic Syndrome......Page 85
05 Dyslipidemia and Type 2 Diabetes Mellitus:\rImplications and Role of Antiplatelet\rAgents in Primary Prevention of\rCardiovascular Disease......Page 91
06 Dyslipidemia: Genetics and Role\rin the Metabolic Syndrome......Page 105
07 Functions of OSBP/ORP Family Proteins\rand Their Relation to Dyslipidemia......Page 139
08 Adipose Tissue and Skeletal Muscle Plasticity\rin Obesity and Metabolic Disease......Page 153
09 Pleiotropic Functions of HDL Lead to\rProtection from Atherosclerosis\rand Other Diseases......Page 185
10 Disrupted VLDL Features and\rLipoprotein Metabolism in Sepsis......Page 211
11Peroxisome Proliferator-Activated Receptor\rβ/δ (PPAR β/δ) as a Potential Therapeutic\rTarget for Dyslipidemia......Page 227
12 Liver Glucokinase and Lipid Metabolism......Page 247
13 Liver Sinusoidal Endothelial Cells and\rRegulation of Blood Lipoproteins......Page 275
14Dyslipidemia and Cardiovascular Risk:\rLipid Ratios as Risk Factors for\rCardiovascular Disease......Page 291
15 Dyslipidemia and Cardiovascular Disease......Page 315
16 Cardiovascular Risk in Tunisian Patients\rwith Bipolar I Disorder......Page 333
17 Dyslipidemia and Mental Illness......Page 361
18 Dyslipidemia Induced by Stress......Page 379
19 Cholesterol and Triglycerides Metabolism\rDisorder in Malignant Hemopathies......Page 403
20 Lipids in the Pathogenesis of\rBenign Prostatic Hyperplasia:\rEmerging Connections......Page 423
21 Dyslipidemia in Patients with Lipodystrophy\rin the Use of Antiretroviral Therapy......Page 439
22 Fenofibrate: Panacea for Aging-Related Conditions?......Page 459
23 Predictors of the Common Adverse Drug Reactions of Statins......Page 471